Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aeolus Pharmaceuticals Inc (AOLS)
OTHER OTC:AOLS
Holding AOLS?
Track your performance easily
AOLS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.01 - $0.01
Previous Close$0.01
Volume10.00
Average Volume (3M)40.00K
Market Cap
$152.00
Enterprise Value-$402.85K
Total Cash (Recent Filing)$403.00K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.53
Next Earnings
May 15, 2017EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume40,000
Standard Deviation1.81
R-Squared0.02
Alpha0.43
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.24
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.52
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.10
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
0.00%
Insiders
0.00%
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
AOLS FAQ
What was Aeolus Pharmaceuticals Inc’s price range in the past 12 months?
Aeolus Pharmaceuticals Inc lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Aeolus Pharmaceuticals Inc’s market cap?
Currently, no data Available
When is Aeolus Pharmaceuticals Inc’s upcoming earnings report date?
Aeolus Pharmaceuticals Inc’s upcoming earnings report date is May 15, 2017 which is 2691 days ago.
How were Aeolus Pharmaceuticals Inc’s earnings last quarter?
Aeolus Pharmaceuticals Inc released its earnings results on Feb 17, 2017. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.01.
Is Aeolus Pharmaceuticals Inc overvalued?
According to Wall Street analysts Aeolus Pharmaceuticals Inc’s price is currently Overvalued.
Does Aeolus Pharmaceuticals Inc pay dividends?
Aeolus Pharmaceuticals Inc does not currently pay dividends.
What is Aeolus Pharmaceuticals Inc’s EPS estimate?
Aeolus Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aeolus Pharmaceuticals Inc have?
Aeolus Pharmaceuticals Inc has 152,086,000 shares outstanding.
What happened to Aeolus Pharmaceuticals Inc’s price movement after its last earnings report?
Aeolus Pharmaceuticals Inc reported an EPS of -$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Aeolus Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in AOLS
---
Company Description
Aeolus Pharmaceuticals Inc
Aeolus Pharmaceuticals, Inc. engages in the development of a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious disease, and diseases of the central nervous system. The company was founded by Brian J. Day in 1994 and is headquartered in Mission Viejo, CA.
---
Technical Analysis
---